Bill Detail
H.R. 4101
Congress: 119
Title
Cancer Drug Parity Act of 2025
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Glenn Grothman [R-WI-6]
Status
Referred to the House Committee on Education and Workforce.
Status as of Aug 5, 8:07 PM · synced 8d ago
Introduced
2025-06-24
Data source mode: congress-gov
Carried by these fly-ins
1Bill Engagement
Cancer Drug Parity Act of 2025
Sponsor
Rep. Glenn Grothman [R-WI-6]R
Status
Referred to the House Committee on Education and Workforce.
Cosponsors
23D · 5R
Lean D
LDA engagement
2 orgs · 2 filings
Top: Cavarocchi Ruscio Dennis Associates, L…
Introduced
2025-06-24
Lobbyists on the case
2 orgs · 4 lobbyists · 2 filings mention H.R. 4101 (Cancer Drug Parity Act of 2025) in LDA disclosures.
Top orgs filing
- Cavarocchi Ruscio Dennis Associates, L.L.C.1 filing · 2 lobs
Lobbyists on this bill
- Katie Gifford2026 Q1
- Stefani Rinehart2026 Q2
+ 2 more in the full intelligence view
Prepared intelligence brief
Put this record in the joined picture.
Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.